News
6d
MedPage Today on MSNFor Your Patients: What to Know About Breast Cancer HER2 StatusHER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for ...
The global HER2-positive breast cancer market is rapidly evolving due to rising prevalence and demand for targeted therapies. HER2-positive breast cancer, characterized by overexpression of HER2 ...
During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone ...
2h
AZoNano on MSNTargeted Nanozyme Therapy for HER2 CancerA new nanozyme-antibody platform selectively targets HER2-positive tumors, disrupting gene expression and reducing metastasis ...
Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.
This study investigates the potential of amygdalin, a natural compound found in almonds, peaches, and apples, as a therapeutic agent for HER2-positive ...
Diagnosis and treatment of breast cancer can differ for patients in rural communities compared with those in urban ...
Panelists highlight that oral endocrine therapies for hormone receptor-positive breast cancer are generally well tolerated ...
For the first time in Australia, a drug that can delay the growth of tumours is available under the Pharmaceutical Benefits ...
Thousands of women with advanced breast cancer could be denied life-extending drugs because of the “unfair” way they are ...
A new medication found to reduce the chance of the most common types of breast cancer recurring will be available to many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results